Drug Database
Back to search

Poland· PL-100453278

Tamsunorm Combi

A tamsulosin und solifenacin product containing solifenacini succinas + tamsulosini hydrochloridum, registered in Poland by Bausch Health Ireland Ltd.. The same ATC class is registered in 9 of our 19 countries.

ATC G04CA53

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedTamsunorm CombiATCG04CA53REGISTER NO.PL-100453278PACKS LISTED2CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about solifenacini succinas + tamsulosini hydrochloridumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Tamsulosin und solifenacin is registered in 9 of 19 countries.

Countries holding a registration under ATC G04CA53 (tamsulosin und solifenacin), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 6 of them publish a price we can compare per daily dose
Search tamsulosin und solifenacin products by name

Tamsulosin und solifenacin · ATC G04CA53

9 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Solifenacini succinas + Tamsulosini hydrochloridum
Manufacturer
Bausch Health Ireland Ltd.
Country
Poland (PL)
ATC code
G04CA53
ATC class
Tamsulosin und Solifenacin
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 2

1 priced
  • gtin
    05397258000926
    30 szt.
    PLN 30.42
  • gtin
    05397313000397

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Tamsulosin und solifenacin in 10 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All tamsulosin und solifenacin products

Authorised across Europe · EMA

The same active substance is authorised in 28 EEA countries. Names it is sold under:

  • Austria · Solicomp, Solifenacin/Tamsulosin Stada
  • Belgium · Solifenacine / Tamsulosine Eurogenerics, Solifenacine/Tamsulosine
  • Bulgaria · Везира, Везомни
  • Cyprus · Nefilin
  • Czechia · Beplasot, Jomil
  • Germany · Solifenacin/Tamsulosin Heumann, Solifenacin/Tamsulosin Ratiopharm
  • Denmark · Solifenacin/Tamsulosin Adalvo, Solifenacin/Tamsulosin Newbury
  • Estonia · Solitombo
  • Spain · Blobax, Daital
  • Finland · Solifenacin/Tamsulosin Stada, Urizia
  • France · Vecalmys
  • United Kingdom (Northern Ireland) · Solifenacin Succinate/Tamsulosin Hydrochloride Altair Science, Solifenacin Succinate/Tamsulosin Hydrochloride Altair Science Limited
  • Greece · Desoltam, Nefilin
  • Croatia · Beplasot, Semquest
  • Hungary · Mingerlan, Örgunderin
  • Ireland · Solifenacin Succinate/Tamsulosin, Solifenacin Succinate/Tamsulosin Hydrochloride Clonmel
  • Iceland · Soltamcin
  • Italy · Luracin, Solifenacina E Tamsulosin Mylan
  • Lithuania · Solitombo
  • Luxembourg · Solifenacine/Tamsulosine, Solifenacine/Tamsulosine Eurogenerics
  • Malta · Jomil
  • Netherlands · Jomil, Mingerlan
  • Norway · Solifenacin/Tamsulosin Newbury, Solifenacin/Tamsulosin Stada
  • Portugal · Blatan, Solifenacina + Tansulosina Generis
  • Romania · Mingerlan, Solifenacin/Tamsulosin Gemax Pharma
  • Sweden · Urizia
  • Slovenia · Semquest, Solifenacin/Tamsulozin Belupo
  • Slovakia · Jomil, Solifenacín/Tamsulozín Belupo

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/2f317b02-2976-4085-93d7-166862d0f759
GET /v1/drugs/2f317b02-2976-4085-93d7-166862d0f759?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki o zmodyfikowanym uwalnianiu",
  "source": "urpl",
  "strength": "6 mg + 0,4 mg",
  "packaging": "05397258000926 ¦ Rp ¦ 147992\n30 tabl.\n05397313000397 ¦ Rp ¦ 152366\n10 tabl.",
  "substance": "Solifenacini succinas 6 mg + Tamsulosini hydrochloridum 0.4 mg",
  "common_name": "Solifenacini succinas + Tamsulosini hydrochloridum",
  "pl_product_id": "100453278",
  "pozwolenie_nr": "27457",
  "auth_procedure": "DCP",
  "authorisation_validity": "2027-11-07"
}
API referenceMCP serverPlans

See everything about tamsulosin und solifenacin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console